Daniel R. Chevallard, Chief Financial Officer at LENZ Therapeutics, Inc. (LENZ), bought 3,188 shares at $15.68 ($50K) on 2024-05-14, disclosed to the SEC on 2024-05-15.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| VIRX | SELL | 2024-02-27 | $2K | — | Filing → |
| VIRX | SELL | 2023-11-28 | $2K | — | Filing → |
| VIRX | SELL | 2023-08-29 | $5K | — | Filing → |